Biomaterials for enhanced immunotherapy

Cunningham, Nicholas, Lapointe, Réjean and Lerouge, Sophie. 2022. « Biomaterials for enhanced immunotherapy ». APL Bioengineering, vol. 6, nº 4. pp. 3155-3169.
Compte des citations dans Scopus : 12.

Preview	PDF Lerouge-S-2022-25993.pdf - Published Version Use licence: Creative Commons CC BY. Download (8MB) | Preview
	PDF Lerouge-S-2022-25993-accepted.pdf - Accepted Version Restricted access to Repository staff only Use licence: All rights reserved to copyright holder. Download (5MB)

Abstract

Cancer immunotherapies have revolutionized the treatment of numerous cancers, with exciting results often superior to conventional treatments, such as surgery and chemotherapy. Despite this success, limitations such as limited treatment persistence and toxic side effects remain to be addressed to further improve treatment efficacy. Biomaterials offer numerous advantages in the concentration, localization and controlled release of drugs, cancer antigens, and immune cells in order to improve the efficacy of these immunotherapies. This review summarizes and highlights the most recent advances in the use of biomaterials for immunotherapies including drug delivery and cancer vaccines, with a particular focus on biomaterials for immune cell delivery.

Item Type:	Peer reviewed article published in a journal
Professor:	Professor Lerouge, Sophie
Affiliation:	Génie mécanique
Date Deposited:	19 Dec 2022 19:14
Last Modified:	20 Dec 2022 15:19
URI:	https://espace2.etsmtl.ca/id/eprint/25993

Actions (login required)

View Item